Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Embecta Corp EMBC

Healthcare Medical Instruments & Supplies
Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with... see more

Recent & Breaking News (NDAQ:EMBC)

embecta to Report Fiscal First Quarter 2024 Financial Results

GlobeNewswire January 24, 2024

embecta Announces FDA 510(k) Submission for Insulin Patch Pump

GlobeNewswire January 9, 2024

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 14, 2023

No embecta-made syringes impacted by FDA safety communication

GlobeNewswire December 1, 2023

embecta to Participate in Investor Conferences

GlobeNewswire November 29, 2023

Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance

GlobeNewswire November 21, 2023

embecta Announces Quarterly Cash Dividend

GlobeNewswire November 21, 2023

embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell

GlobeNewswire October 31, 2023

embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire October 25, 2023

embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference

GlobeNewswire September 6, 2023

Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results

GlobeNewswire August 8, 2023

embecta Announces Quarterly Cash Dividend

GlobeNewswire August 8, 2023

embecta to Report Fiscal Third Quarter 2023 Financial Results

GlobeNewswire July 11, 2023

UPDATE -- embecta to Participate in Investor Conferences

GlobeNewswire May 15, 2023

embecta to Participate in Investor Conferences

GlobeNewswire May 15, 2023

Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results

GlobeNewswire May 12, 2023

embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes

GlobeNewswire May 12, 2023

embecta Announces Quarterly Cash Dividend

GlobeNewswire May 12, 2023

embecta to Report Fiscal Second Quarter 2023 Financial Results

GlobeNewswire April 20, 2023

embecta sponsors educational symposium at ATTD 2023

GlobeNewswire February 22, 2023